MENLO PARK, Calif.–(BUSINESS WIRE)–#MultipleSclerosis–Octave Bioscience, Inc., a commercial-stage precision medicine company pioneering biomarker-driven solutions for multiple sclerosis, Parkinson’s disease, and…
MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe,…
